Molecular modelling on multiepitope-based vaccine against SARS-CoV-2 using immunoinformatics, molecular docking, and...

Area of Science:

• Virology
• Immunology
• Computational Biology

Background:

• The COVID-19 pandemic caused by SARS-CoV-2 remains a global health crisis.
• Emerging SARS-CoV-2 variants with mutations in structural proteins reduce the efficacy of existing vaccines.
• Predicting and countering new variants necessitates the development of novel or modified vaccine strategies.

Purpose of the Study:

• To design a potential vaccine candidate against SARS-CoV-2 using computational approaches.
• To create a multiepitope-based vaccine (MEV) targeting structural proteins of SARS-CoV-2.
• To evaluate the potential immunogenicity and broad-spectrum efficacy of the designed MEV.

Main Methods:

• Immunoinformatics analysis was employed to identify potential epitopes.
• Molecular docking was used to assess the binding affinity of vaccine constructs.
• Molecular dynamics (MD) simulations were performed to analyze the stability and behavior of the vaccine construct.

Main Results:

• A multiepitope-based vaccine (MEV) construct was successfully designed utilizing SARS-CoV-2 structural proteins.
• Computational analyses indicated that the designed MEV has the potential to induce a robust immune response.
• The MEV construct demonstrated promising characteristics for broad-spectrum efficacy against SARS-CoV-2 and its variants.

Conclusions:

• The in silico designed MEV represents a promising vaccine candidate against SARS-CoV-2.
• This computational approach offers a rapid and effective strategy for vaccine development against rapidly mutating viruses.
• The developed MEV is expected to be effective against existing and potential future SARS-CoV-2 variants.